课题基金 / 基金详情

Drug Targets for Treatment of Nicotine Dependence

Drug Targets for Treatment of Nicotine Dependence
治疗尼古丁依赖的药物靶点
批准号：
7514124
负责人：
Ronald John Lukas
金额：
$17.37万
依托单位：
RESEARCH TRIANGLE INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-06-01 至 2010-05-31
来源：
https://reporter.nih.gov/project-details/7514124
关键词：
AcuteAdverse effectsAffectAgonistAntidepressive AgentsAttentionBehaviorBehavioralBehavioral ParadigmBindingBiologicalBiological AssayBupropionBupropion/NicotineCell LineCellsChemicalsChronicClinicalCognitionComplementDataDopamineDoseDrug AddictionDrug Delivery SystemsDrug EvaluationDrug InteractionsDrug ReceptorsDrug effect disorderEmotionsExerciseExperimental ModelsExposure toGoalsHumanHuman Cell LineIn VitroInvestigationIonsLaboratoriesLigandsLong-Term EffectsMediatingMethodsModelingModificationMolecular TargetMoodsNatureNervous System PhysiologyNervous system structureNeuraxisNeurotransmittersNicotineNicotine DependenceNicotinic ReceptorsNomenclatureOutcomePharmaceutical PreparationsPharmacodynamicsPlayProcessPropertyProtocols documentationRelative (related person)ResearchResearch DesignRoleRole playing therapySelection CriteriaSelf AdministrationSeriesSiteSpecific qualifier valueSynapsesTestingTherapeuticTherapeutic EffectTobaccoWorkanalogbaseclinical efficacydesigndrug efficacyhigh throughput screeningin vivoinhibitor/antagonistinterestmonoamineneurochemistryneurotransmissionnicotine replacementnoradrenaline transporternovelprogramsradioligandreceptor functionresearch studysmoking cessation

项目成果

Ronald John Lukas的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alpha9*-Nicotinic Receptors in Autoimmunity and Inflammation
Alpha9*-Nicotinic Receptors in Autoimmunity and Inflammation
Drug Targets for Treatment of Nicotine Dependence
  • 批准号：
    7620452
  • 项目类别：
  • 资助金额：
    $18.97万
  • 财政年份：
    2008
  • 负责人：
    Ronald John Lukas
  • 依托单位：
    RESEARCH TRIANGLE INSTITUTE
Molecular Bases for Effects of Nicotine
海外基金